Australia's most trusted
source of pharma news
Saturday, 27 April 2024
Posted 23 June 2022 AM
Five new drugs have hit the TGA's review list with cancer treatments once again leading the pack.
Most of these medicines have joined the TGA's previously published May list, including Janssen's biologic teclistamab.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.